• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与对照组织相比,对Dupuytren病结节上方的皮下脂肪、筋膜和皮肤进行差异基因表达分析。

Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.

作者信息

Shih Barbara, Brown Jason J, Armstrong Daniel J, Lindau Tommy, Bayat Ardeshir

机构信息

Plastic & Reconstructive Surgery Research, Manchester Interdisciplinary Biocentre, University of Manchester, Manchester, UK.

出版信息

Hand (N Y). 2009 Sep;4(3):294-301. doi: 10.1007/s11552-009-9164-0. Epub 2009 Jan 29.

DOI:10.1007/s11552-009-9164-0
PMID:19184239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2724615/
Abstract

Dupuytren's disease (DD) is a benign fibroproliferative tumor with an unknown etiology and high recurrence postsurgery. Several observations suggest the possible involvement of skin overlying nodule (SON) and the subcutaneous fat in the pathogenesis of DD. This study aims to (1) compare the gene expression levels of SON and subcutaneous fat in DD and normal subjects and (2) to compare transverse palmar fascia (Skoog's fibers) from DD patients as internal control tissue, with palmar fascia (transverse carpal ligament) from patients undergoing carpal tunnel release as external control. Skin, fat, and fascia were obtained from five DD patients of Caucasian origin (age = 66 +/- 14) and from five control subjects (age = 57 +/- 19) undergoing carpal tunnel release. Total ribonucleic acids was extracted from each sample and used for complementary deoxyribonucleic acid synthesis. Real-time quantitative polymerase chain reaction was used to assess the gene expression levels of six candidate genes: A disintegrin and metalloproteinase domain (ADAM12), aldehyde dehydrogenase 1 family member A1 (ALDH1A1), iroquois homeoboxprotein 6 (IRX6), periostin, osteoblast specific factor, proteoglycan 4, and tenascin C. Using independent t test, ADAM12, ALDH1A1, and IRX6 expression levels in DD fats were significantly (p < 0.05) higher than those in the controls. There is no significant difference in the gene expression levels of all six genes when comparing disease and control fascia and skin. Interestingly, ADAM12 up-regulation has also been observed in several other fibrotic and proliferative disorders. In conclusion, this study demonstrates potential roles for subcutaneous fat in DD pathogenesis as well as supports the use of transverse palmar fascia as appropriate control tissues in DD research.

摘要

掌腱膜挛缩症(DD)是一种病因不明且术后复发率高的良性纤维增生性肿瘤。多项观察结果表明,结节上方皮肤(SON)和皮下脂肪可能参与了DD的发病机制。本研究旨在:(1)比较DD患者与正常受试者SON和皮下脂肪的基因表达水平;(2)将DD患者的掌横筋膜(斯科格纤维)作为内部对照组织,与接受腕管松解术患者的掌筋膜(腕横韧带)作为外部对照进行比较。从5名白种人DD患者(年龄 = 66 ± 14岁)和5名接受腕管松解术的对照受试者(年龄 = 57 ± 19岁)获取皮肤、脂肪和筋膜。从每个样本中提取总核糖核酸并用于互补脱氧核糖核酸合成。采用实时定量聚合酶链反应评估6个候选基因的基因表达水平:解整合素和金属蛋白酶结构域(ADAM12)、醛脱氢酶1家族成员A1(ALDH1A1)、Iroquois同源盒蛋白6(IRX6)、骨膜蛋白、成骨细胞特异性因子、蛋白聚糖4和腱生蛋白C。使用独立t检验,DD脂肪中ADAM12、ALDH1A1和IRX6的表达水平显著高于对照组(p < 0.05)。比较疾病组和对照组的筋膜及皮肤时,所有6个基因的基因表达水平无显著差异。有趣的是,在其他几种纤维化和增殖性疾病中也观察到了ADAM12的上调。总之,本研究证明了皮下脂肪在DD发病机制中的潜在作用,并支持在DD研究中使用掌横筋膜作为合适的对照组织。

相似文献

1
Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.与对照组织相比,对Dupuytren病结节上方的皮下脂肪、筋膜和皮肤进行差异基因表达分析。
Hand (N Y). 2009 Sep;4(3):294-301. doi: 10.1007/s11552-009-9164-0. Epub 2009 Jan 29.
2
Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.通过对特定疾病表型的成纤维细胞与组织活检进行比较分析,鉴定掌腱膜挛缩症中的生物标志物。
J Hand Surg Am. 2009 Jan;34(1):124-36. doi: 10.1016/j.jhsa.2008.09.017.
3
Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.在杜普伊特伦氏病的结节周围脂肪和皮肤中鉴定间充质干细胞:成肌纤维细胞的潜在来源,对发病机制和治疗有影响。
Stem Cells Dev. 2012 Mar 1;21(4):609-22. doi: 10.1089/scd.2011.0140. Epub 2011 Jul 19.
4
Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.使用转录组信息学分析定义的掌腱膜挛缩症的分子表型描述符。
J Hand Surg Am. 2008 Mar;33(3):359-72. doi: 10.1016/j.jhsa.2007.11.010.
5
Expression of a novel gene, MafB, in Dupuytren's disease.一种新基因MafB在掌腱膜挛缩症中的表达
J Hand Surg Am. 2006 Feb;31(2):211-8. doi: 10.1016/j.jhsa.2005.09.007.
6
WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.在源自杜普伊特伦挛缩症组织的原代成纤维细胞中,WT1表达增加。
J Cell Commun Signal. 2015 Dec;9(4):347-52. doi: 10.1007/s12079-015-0293-7. Epub 2015 Jun 30.
7
Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.基质金属蛋白酶及其抑制剂在杜普伊特伦氏挛缩症患者的 cords 和 nodules 中的表达。
Arch Orthop Trauma Surg. 2009 Nov;129(11):1453-9. doi: 10.1007/s00402-008-0726-3. Epub 2008 Aug 30.
8
A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.掌腱膜挛缩症中基质降解金属蛋白酶的完整表达谱。
J Hand Surg Am. 2007 Mar;32(3):343-51. doi: 10.1016/j.jhsa.2006.12.010.
9
Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.佩罗尼氏病与掌腱膜挛缩症之间基因表达谱的比较。
Urology. 2004 Aug;64(2):399-404. doi: 10.1016/j.urology.2004.04.006.
10
Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing.掌腱膜挛缩症代谢物分析揭示了初始短期成纤维细胞培养后的变化。
Mol Biosyst. 2012 Sep;8(9):2274-88. doi: 10.1039/c2mb25173f. Epub 2012 Jul 6.

引用本文的文献

1
Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies.《掌腱膜挛缩症的药物治疗:当前和新策略》。
J Hand Surg Am. 2023 Aug;48(8):810-821. doi: 10.1016/j.jhsa.2023.02.003. Epub 2023 Mar 17.
2
Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells.骨膜蛋白剪接变异体在软骨细胞和韧带祖细胞中的独特表达模式。
FASEB J. 2019 Jul;33(7):8386-8405. doi: 10.1096/fj.201802281R. Epub 2019 Apr 16.
3
Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren's contracture.掌腱膜挛缩症患者手掌皮下组织血管形成的评估
World J Orthop. 2018 Sep 18;9(9):130-137. doi: 10.5312/wjo.v9.i9.130.
4
Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.治疗增殖性良性疾病时的放射生物学基础
Front Immunol. 2017 May 3;8:519. doi: 10.3389/fimmu.2017.00519. eCollection 2017.
5
Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.关于分子因素和成纤维细胞在掌腱膜挛缩症发病机制中作用的最新进展。
J Cell Commun Signal. 2016 Dec;10(4):315-330. doi: 10.1007/s12079-016-0331-0. Epub 2016 Jun 7.
6
Periostin as a multifunctional modulator of the wound healing response.骨膜蛋白作为伤口愈合反应的多功能调节剂。
Cell Tissue Res. 2016 Sep;365(3):453-65. doi: 10.1007/s00441-016-2426-6. Epub 2016 May 28.
7
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.通过整合患者和细胞系基因组分析鉴定与卡培他滨诱导的手足综合征相关的基因变异
Pharmacogenet Genomics. 2014 May;24(5):231-7. doi: 10.1097/FPC.0000000000000037.
8
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity.FAP、ADAM12、WISP1 和 SOX11 的表达在侵袭性纤维瘤病中具有异质性,并与肿瘤活性的组织学特征在空间上相关。
Cancer Med. 2014 Feb;3(1):81-90. doi: 10.1002/cam4.160. Epub 2013 Nov 26.
9
Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.在杜普伊特伦氏病的结节周围脂肪和皮肤中鉴定间充质干细胞:成肌纤维细胞的潜在来源,对发病机制和治疗有影响。
Stem Cells Dev. 2012 Mar 1;21(4):609-22. doi: 10.1089/scd.2011.0140. Epub 2011 Jul 19.
10
Scientific understanding and clinical management of Dupuytren disease.Dupuytren 病的科学认识和临床管理。
Nat Rev Rheumatol. 2010 Dec;6(12):715-26. doi: 10.1038/nrrheum.2010.180. Epub 2010 Nov 9.

本文引用的文献

1
Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.通过对特定疾病表型的成纤维细胞与组织活检进行比较分析,鉴定掌腱膜挛缩症中的生物标志物。
J Hand Surg Am. 2009 Jan;34(1):124-36. doi: 10.1016/j.jhsa.2008.09.017.
2
A survey of clinical manifestations and risk factors in women with Dupuytren's disease.掌腱膜挛缩症女性患者的临床表现及危险因素调查。
Acta Orthop Belg. 2008 Aug;74(4):456-60.
3
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.实体瘤中的癌症干细胞:越来越多的证据与未解决的问题
Nat Rev Cancer. 2008 Oct;8(10):755-68. doi: 10.1038/nrc2499. Epub 2008 Sep 11.
4
Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings.用于评估杜普伊特伦挛缩症疾病严重程度的改良图比阿纳分期系统——初步临床研究结果
Hand (N Y). 2008 Jun;3(2):80-6. doi: 10.1007/s11552-007-9071-1. Epub 2007 Sep 11.
5
Analyzing real-time PCR data by the comparative C(T) method.通过比较Ct法分析实时荧光定量PCR数据。
Nat Protoc. 2008;3(6):1101-8. doi: 10.1038/nprot.2008.73.
6
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.易洛魁同源框基因5在人前列腺癌中受1,25-二羟基维生素D3调控,并调节LNCaP前列腺癌细胞中的细胞凋亡和细胞周期。
Clin Cancer Res. 2008 Jun 1;14(11):3562-70. doi: 10.1158/1078-0432.CCR-07-4649.
7
Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases.癌症疾病中的乙醇脱氢酶(ADH)和乙醛脱氢酶(ALDH)。
Clin Chim Acta. 2008 Sep;395(1-2):1-5. doi: 10.1016/j.cca.2008.05.001. Epub 2008 May 8.
8
Wound repair and regeneration.伤口修复与再生。
Nature. 2008 May 15;453(7193):314-21. doi: 10.1038/nature07039.
9
Twenty-five years of quantitative PCR for gene expression analysis.用于基因表达分析的定量PCR技术的25年发展历程。
Biotechniques. 2008 Apr;44(5):619-26. doi: 10.2144/000112776.
10
Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.使用转录组信息学分析定义的掌腱膜挛缩症的分子表型描述符。
J Hand Surg Am. 2008 Mar;33(3):359-72. doi: 10.1016/j.jhsa.2007.11.010.